Inspira Technologies Oxy B.H.N. Ltd - Warrants (30/06/2026) Profit Margin

Inspira Technologies Oxy B.H.N. Ltd - Warrants (30/06/2026) (IINNW) currently reports a profit margin of -4373.01% as of June 2025. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Inspira Technologies Oxy B.H.N. Ltd - Warrants (30/06/2026)'s profit margin history and peer comparisons.

Inspira Technologies Oxy B.H.N. Ltd - Warrants (30/06/2026)'s profit margin of -4373.01% is lower than the Healthcare sector average of 13.89%. That is roughly 31576.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Inspira Technologies Oxy B.H.N. Ltd - Warrants (30/06/2026)'s current -4373.01% should be judged against Healthcare norms (sector average: 13.89%) and against IINNW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -4373.01%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Inspira Technologies Oxy B.H.N. Ltd - Warrants (30/06/2026), and consider following IINNW for alerts when major investors trade the stock.

Inspira Technologies Oxy B.H.N. Ltd - Warrants (30/06/2026) is classified in the Healthcare sector. On profit margin, it currently shows -4373.01% versus a sector average near 13.89%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IINNW with unrelated industries.